AYTU BIOPHARMA, INC Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
AYTU BIOPHARMA, INC (AYTU) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $32.17 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-11-14
- 2023-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $32.17M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $39.36M.
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $40.91M.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $45.82M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2023-09-30 | $32.17M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $39.36M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $40.91M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $45.82M 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $48.35M 10-Q · filed 2023-11-14 | $53.91M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $44.31M 10-Q · filed 2023-11-14 | $46.09M 10-K · filed 2022-09-27 |
| 2022-03-31 | $57.75M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $105.54M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $111.50M 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $137.57M 10-K · filed 2023-10-12 | |
| 2020-06-30 | $95.02M 10-K · filed 2022-09-27 | |
| 2015-03-31 | $551.26K 10-Q · filed 2015-05-19 | |
| 2014-06-30 | $5.37M 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |